

3-乙基-2-乙酰吡嗪缩4-甲基氨基硫脲Cu(Ⅱ)配合物的合成、结构和DNA结合性质
English
Three Cu(Ⅱ) Complexes with 1-(3-Ethylpyrazin-2-yl)ethylidene)-4-methylthiosemicarbazide: Crystal Structures and DNA-Binding Properties
-
Key words:
- complex
- / crystal structure
- / Cu(Ⅱ)
- / pyrazine
- / thiosemicarbazone
- / DNA-binding property
-
Pyrazine-containing thiosemicarbazones (TSCs) have received considerable attention in chemistry and biology, primarily due to their marked and various biological properties[1-6]. Currently the most famous drug candidate of this class of compounds is Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone), which entered several phase Ⅰ and Ⅱ clinical trials as an antitumor chemotherapeutic agent[5-6]. In addition, earlier studies revealed that the biological properties of TSCs are often modulated by metal ion coordination[7-10]. In this regard, the complexes of TSCs bearing pyrazine unit usually displayed higher biological activity than the parent ligands due to the so-called metal-ligand synergism effect. Our previous work also shows that the interactions of the Ni(Ⅱ) and Zn(Ⅱ) complexes with DNA are stronger than that of the thiosemicarbazone ligand, namely 1-(3-ethylpyrazin-2-yl)ethylidene)-4-methylthiosemicarbazide (HL)[11].
On the other hand, Cu(Ⅱ) containing anticancer agents are promising leads for next generation of metal-based anticancer agents because Cu(Ⅱ) plays a significant role in biological systems[8-9]. Furthermore, diverse structures of Cu(Ⅱ) complexes with TSCs could be obtained by varying the corresponding anions. As part of our continuous work on searching for bioactive compounds, three Cu(Ⅱ) complexes with HL were synthesized and characterized by X-ray diffraction methods. In addition, their DNA-binding properties have been investigated in detail.
Scheme 1
Scheme 1. Synthetic route of the TSC ligand HL[11]1. Experimental
1.1 Materials and measurements
Solvents and starting materials for syntheses were purchased commercially and used as received. Ligand HL was synthesized by the method reported by us[11]. Elemental analyses were carried out on an Elemental Vario EL analyzer. The IR spectra (ν=4 000~400 cm-1) were determined by the KBr pressed disc method on a Bruker V70 FT-IR spectrophotometer. The UV spectra were recorded on a Purkinje General TU-1800 spectrophotometer. DNA-binding properties of the ligand and three complexes were measured using literature method via emission spectra[12].
1.2 Syntheses of complexes 1~3
Complex 1 was synthesized by reacting HL (0.5 mmol) with equimolar amount of CuBr2, CuCl2 or CuSO4 in methanol/DMF (10 mL, 1:1, V/V) solution at room temperature, respectively. The crystals suitable for X-ray diffraction analysis were obtained by evaporating the reaction solutions at room temperature.
1: Black blocks. Yield: 77%. Anal. Calcd. for C13H21N6OSBrCu(%): C, 34.48; H, 4.67; N, 18.56; S, 7.08. Found(%): C, 34.25; H, 4.86; N, 18.28; S, 6.89. FT-IR (cm-1): ν(N=C) 1 523, ν(N=C, pyrazine) 1 456, ν(S=C) 858.
2: Black plates. Yield 65%. Anal. Calcd. for C10H18N5O2SClCu(%): C, 32.35; H, 4.89; N, 18.86; S, 8.63. Found(%): C, 32.15; H, 4.99; N, 19.01; S, 8.53. FT-IR (cm-1): ν(N=C) 1 541, ν(N=C, pyrazine) 1 498, ν(S=C) 856.
3: Black rods. Yield 53%. Anal. Calcd. for C21H34N10O6S3Cu2(%): C, 33.82; H, 4.59; N, 18.78; S, 12.90. Found(%): C, 33.45; H, 4.39; N, 18.75; S, 12.79. FT-IR (cm-1): ν(N=C) 1 541, ν(N=C, pyrazine) 1 500, ν(S=C) 860.
1.3 X-ray crystallography
The X-ray diffraction measurement for complexes 1 (crystal size: 0.16 nm×0.12 nm×0.10 mm), 2 (crystal size: 0.25 nm×0.12 nm×0.04 mm), and 3 (crystal size: 0.40 nm×0.20 nm×0.20 mm) was performed on a Bruker SMART APEX Ⅱ CCD diffractometer equipped with a graphite monochromatized Mo Kα radiation (λ=0.071 073 nm) by using φ-ω scan mode. Semi-empirical absorption correction was applied to the intensity data using the SADABS program[13]. The structures were solved by direct methods and refined by full matrix least-square on F2 using the SHELXTL-97 program[14]. All non-hydrogen atoms were refined anisotropically. The H atoms for the O1 and O2 atoms of complex 2 were not added due to the special symmetric positions of these atoms. All the other H atoms were positioned geometrically and refined using a riding model. Details of the crystal parameters, data collection and refinements for complexes 1~3 are summarized in Table 1.
Table 1
1 2 3 Empirical formula C13H21N6OSBrCu C10H18N5O2SClCu C21H34N10O6S3Cu2 Formula weight 452.87 371.34 745.84 T/K 296(2) 293(2) 293(2) Crystal system Triclinic Triclinic Triclinic Space group P1 P1 P1 a / nm 0.773 2(6) 0.751 97(16) 0.972 81(17) b/ nm 0.982 2(9) 0.948 0(2) 1.116 5(2) c / nm 1.231 2(9) 1.174 0(3) 1.516 2(3) α/(°) 86.26(3) 110.591(3) 91.264(3) β/(°) 76.13(3) 92.228(3) 93.442(3) γ/(°) 74.49(3) 99.401(3) 109.496(3) V/ nm3 0.874 7(12) 0.768 7(3) 1.548 0(5) Z 2 2 2 Dc / (g.cm-3) 1.719 1.604 1.600 Goodness-of-fit (GOF) on F2 1.002 1.077 1.060 Final R indices [I > 2σ(I)] R1=0.053 2, wR2=0.150 1 R1=0.031 8, wR2=0.094 5 R1=0.037 7, wR2=0.109 2 R indices (all data) R1=0.082 6, wR2=0.136 5 R1=0.034 6, wR2=0.092 0 R1=0.044 9, wR2=0.103 7 CCDC: 1884254, 1; 1884255, 2; 1884256, 3.
2. Results and discussion
2.1 Crystal structures description
A diamond drawing of complexes 1~3 is shown in Fig. 1. Selected bond distances and angles are listed in Table 2. The TSC ligand is anionic with C-S bond length in a range of 0.168 4(4)~0.173 2(4) nm in all three complexes. As shown in Fig. 1a and 1b, the structures of complexes 1 and 2 are similar, and the center Cu(Ⅱ) ion in each complex is coordinated by one thiosemicarbazone ligand with N2S donor set and one halide ion (bromide for 1 and chloride for 2), thus possessing a distorted planar square coordination geometry. The intermolecular N-H…O hydrogen bond between the complex and free DMF molecule is found in the crystal of 1. It should be noted that the O1 and O2 atoms occupy in special symmetric position in complex 2 and the H atoms for them are not added, while both of crystal water molecules are involved in a ladder-like supramolecular network, including inter-molecular N-H…O, O-H…N, O-H…Cl and O-H…O hydrogen bonds.
Figure 1
Table 2
1 Cu1-N1 0.202 0(5) Cu1-N3 0.190 9(5) Cu1-S1 0.220 2(2) Cu1-Br1 0.232 4(19) S1-Cu1-Br1 96.56(8) N3-Cu1-N1 79.2(2) N3-Cu1-S1 85.38(16) N1-Cu1-S1 163.04(14) N3-Cu1-Br1 177.64(15) N1-Cu1-Br1 99.08(15) 2 Cu1-N1 0.202 5(2) Cu1-N3 0.195 8(2) Cu1-S1 0.224 18(8) Cu1-C11 0.222 86(8) N3-Cu1-N1 79.43(9) N3-Cu1-C11 177.49(6) N3-Cu1-S1 85.74(7) N1-Cu1-C11 98.17(6) N1-Cu1-S1 162.98(6) C11-Cu1-S1 96.74(3) 3 Cu1-O1 0.193 4(2) Cu1-N1 0.200 6(3) Cu1-N3 0.194 0(3) Cu1-S1 0.226 83(9) Cu1-S2 0.283 21(10) Cu2-N6 0.201 1(3) Cu2-N8 0.194 3(3) Cu2-O2 0.194 6(2) Cu2-S1 0.277 58(10) Cu2-S2 0.226 50(9) O1-Cu1-N3 172.39(10) O1-Cu1-N1 92.70(10) O1-Cu1-S1 100.73(7) O1-Cu1-S2 92.80(8) O2-Cu2-N6 96.10(10) O2-Cu2-S1 97.20(8) O2-Cu2-S2 96.39(7) S1-Cu1-S2 95.37(3) S2-Cu2-S1 97.01(3) N1-Cu1-S1 164.24(8) N1-Cu1-S2 92.14(8) N3-Cu1-N1 80.00(10) N3-Cu1-S1 86.20(8) N3-Cu1-S2 89.63(8) N6-Cu2-S2 162.31(8) N6-Cu2-S1 93.80(8) N8-Cu2-N6 79.86(10) N8-Cu2-S2 86.15(8) N8-Cu2-O2 171.97(10) N8-Cu2-S1 90.02(8) Table 3
D-H …A d(D-H) / nm d(H …A) / nm d(D …A)/ nm ∠D-H…A/(°) 1 N5-H5 …O1 0.086 0.198 0.279 1(8) 158 2 O2 …Cllⅰ — — 0.331 9 — O2 …O2ⅰ — — 0.281 9 — O1 …O1ⅱ — — 0.282 2 — O1 …N2ⅲ — — 0.229 5 — N5-H5 …O1 0.086 0.210 0.293 2(3) 162.0 3 N5-H5 …O6ⅳ 0.086 0.211 0.293 2(5) 160.4 N10-H10 …O5 0.086 0.207 0.286 4(4) 153.5 O5-H5D …O4ⅴ 0.085 0.198 0.282 3(4) 168.6 O5-H5C …N2ⅵ 0.085 0.225 0.301 6(4) 150.8 O6-H4 …O6 0.082 0.210 0.279 8(4) 142.8 Symmetry codes: ⅰ 1-x, -y, -1-z; ⅱ 1-x, -1-y, -1-z; ⅲ -1+x, -1+y, -1+z; ⅳ x+1, y, z; ⅴ x, -1+y, z; ⅵ -x, 1-y, -z In the asymmetric unit of complex 3, there exist one dimeric Cu(Ⅱ) complex, one free water and one methanol molecules. Two Cu(Ⅱ) ions were doubly bridged by two S atoms of two TSC ligands to form a Cu2S2 core with Cu…Cu distance of 0.318 0 nm. Each of the Cu(Ⅱ) ions is also coordinated by two N atoms from one TSC ligand and one O atom from the η2-SO42- anion at the outer axial site. According to the Addison rule[15], the geometric index τ is 0.136 and 0.161 for Cu1 and Cu2, respectively, indicating that the coordination geometry of each Cu(Ⅱ) ion is best described as a distorted tetragonal pyramid rather than trigonal biyramid. In addition, in the solid state, intermolecular N-H…O, O-H…N, and O-H…O hydrogen bonds are helpful to construct a three dimensional supramolecular network.
2.2 IR spectra
The infrared spectral bands most useful for determining the coordination mode of the ligand are the ν(N=C), ν(N=C, pyrazine) and ν(S=C) vibrations. Such three bonds of the free TSC ligand were found at 1 544, 1 502 and 863 cm-1 [11], respectively, while they shifted to lower frequency in complexes 1~3, clearly indicating the coordination of imine N, pyrazine N and S atoms[1-2, 16-17]. It is in accordance with the X-ray diffraction analysis result.
2.3 UV spectra
The UV spectra of HL[11] and complexes 1~3 in DMSO solution (concentration: 10 μmol·L-1) were measured at room temperature (Fig. 2). The spectrum of HL featured only one main band located around 299 nm (ε=34 026 L·mol-1·cm-1)[11], which could be assigned to characteristic π-π* transition of pyrazine unit[12]. Similar bands were observed at 324 nm (ε= 39 263 L·mol-1·cm-1), 327 nm (ε=18 260 L·mol-1·cm-1) and 317 nm (ε=139 830 L·mol-1·cm-1) in complexes 1~3, respectively. However, the new bonds at 437 nm (ε=27 771 L·mol-1·cm-1), 432 nm (ε=16 202 L·mol-1·cm-1) and 433 nm (ε=87 930 L·mol-1·cm-1) could be observed in spectra of 1~3, respectively, probably due to the ligand-to-metal charge transfer (LMCT)[16]. This indicates that an extended conjugation is formed in anionic ligand after complexation in the complexes.
Figure 2
2.3 EB-DNA binding study by fluorescence spectrum
It is well known that EB can intercalate into DNA to induce strong fluorescence emission. Competitive binding of other drugs to DNA and EB will result in displacement of bounding EB and a decrease in the fluorescence intensity[15]. Fig. 3 shows the effects of the ligand and complexes 1~3 (10 μmol·L-1) on the fluorescence spectra of EB-DNA system. The fluorescence intensities of EB bound to ct-DNA at about 600 nm showed remarkable decreasing trend with the increasing concentration of each tested compound, indicating that some EB molecules are released into solution after the exchange with the compound. The quenching of EB bound to DNA by the compound is in agreement with the linear Stern-Volmer equation: I0/I=1+Ksqr[16], where I0 and I represent the fluorescence intensities in the absence and presence of quencher, respectively; Ksq is the linear Stern-Volmer quenching constant; r is the ratio of the concentration of quencher and DNA. In the quenching plots of I0/I versus r, Ksq values are given by the slopes. The Ksq values were 0.484, 1.465, 1.133 and 1.827 for HL[11] and complexes 1~3, respectively, indicating that interaction of the complexes with DNA is much stronger than HL[11]. This is probably due to the structure rigidity and metal-ligand synergism effect of the complexes[13]. Complex 3 exhibits the highest activity among the three complexes, which is consistent with the demonstration that the activity of polynuclear complex is stronger than that of mononuclear one[18].
Figure 3
3. Conclusions
Three complexes with a pyrazine-containing thiosemicarbazone ligand were prepared and characterized by single-crystal X-ray crystallography. In addition, the fluorescence spectra indicated that the interaction of the complexes to DNA is stronger than that of the ligand HL. Particularly, complex 3 exhibits the highest activity among the three complexes, which is consistent with the demonstration that the activity of polynuclear complex is stronger than that of mononuclear one. Further research is needed to better determine the relationship between structures and activities.
-
-
[1]
Li M X, Zhang L Z, Yang M, et al. Bioorg. Med. Chem. Lett., 2012, 22:2418-2433 doi: 10.1016/j.bmcl.2012.02.024
-
[2]
Li M X, Zhang L Z, Zhang D, et al. Eur. J. Med. Chem., 2011, 46:4383-4390 doi: 10.1016/j.ejmech.2011.07.009
-
[3]
Qi J, Deng J, Qian K, et al. Eur. J. Med. Chem., 2017, 134:34-42 doi: 10.1016/j.ejmech.2017.04.009
-
[4]
Rogolino D, Cavazzoni A, Gatti A, et al. Eur. J. Med. Chem., 2017, 128:140-153 doi: 10.1016/j.ejmech.2017.01.031
-
[5]
Erxleben A. Coord. Chem. Rev., 2018, 360:92-121 doi: 10.1016/j.ccr.2018.01.008
-
[6]
Dubey P, Gupta S, Singh A K, et al. Dalton Trans., 2018, 47:3746-3774
-
[7]
Zhang X M, Guo H, Li Z S, et al. Eur. J. Med. Chem., 2015, 101:419-430 doi: 10.1016/j.ejmech.2015.06.047
-
[8]
Sangeetha K G, Aravindakshan K K. Inorg. Chim. Acta, 2018, 469:387-396 doi: 10.1016/j.ica.2017.09.057
-
[9]
Milunovic M N M, Dobrova A, Novitchi G, et al. Eur. J. Inorg. Chem., 2017, 469:4473-4483
-
[10]
Wang Y T, Fang Y, Zhao M, et al. MedChemComm, 2017, 8(11):2125-2132 doi: 10.1039/C7MD00415J
-
[11]
王碗碗, 王元, 吴伟娜, 等.无机化学学报, 2018, 34:1511-1516 doi: 10.11862/CJIC.2018.196WANG Wan-Wan, WANG Yuan, WU Wei-Na, et al. Chinese J. Inorg. Chem., 2018, 34:1511-1516 doi: 10.11862/CJIC.2018.196
-
[12]
林龙, 李先宏, 张波, 等.无机化学学报, 2017, 33:143-148 doi: 10.11862/CJIC.2016.283LIN Long, LI Xian-Hong, ZHANG Bo, et al. Chinese J. Inorg. Chem., 2017, 33:143-148 doi: 10.11862/CJIC.2016.283
-
[13]
Sheldrick G M. SADABS, University of Göttingen, Germany, 1996.
-
[14]
Sheldrick G M. SHELX-97, Program for the Solution and the Refinement of Crystal Structures, University of Göttingen, Germany, 1997.
-
[15]
Addison A W, Rao T N. J. Chem. Soc. Dalton Trans., 1984:1349-1356
-
[16]
毛盼东, 赵晓雷, 邵志鹏, 等.无机化学学报, 2017, 33:890-896 doi: 10.11862/CJIC.2017.109MAO Pan-dong, ZHAO Xiao-Lei, SHAO Zhi-Peng, et al. Chinese J. Inorg. Chem., 2017, 33:890-896 doi: 10.11862/CJIC.2017.109
-
[17]
Nakamoto K. Infrared and Raman Spectra of Inorganic and Coordination Compounds. 4th Ed. New York:Wiley, 1986:257
-
[18]
Tu C, Shao Y, Gan N, et al. Inorg. Chem., 2004, 43:4761-4766 doi: 10.1021/ic049731g
-
[1]
-
Scheme 1 Synthetic route of the TSC ligand HL[11]
Table 1. Crystal data and structure refinement for complexes 1~3
1 2 3 Empirical formula C13H21N6OSBrCu C10H18N5O2SClCu C21H34N10O6S3Cu2 Formula weight 452.87 371.34 745.84 T/K 296(2) 293(2) 293(2) Crystal system Triclinic Triclinic Triclinic Space group P1 P1 P1 a / nm 0.773 2(6) 0.751 97(16) 0.972 81(17) b/ nm 0.982 2(9) 0.948 0(2) 1.116 5(2) c / nm 1.231 2(9) 1.174 0(3) 1.516 2(3) α/(°) 86.26(3) 110.591(3) 91.264(3) β/(°) 76.13(3) 92.228(3) 93.442(3) γ/(°) 74.49(3) 99.401(3) 109.496(3) V/ nm3 0.874 7(12) 0.768 7(3) 1.548 0(5) Z 2 2 2 Dc / (g.cm-3) 1.719 1.604 1.600 Goodness-of-fit (GOF) on F2 1.002 1.077 1.060 Final R indices [I > 2σ(I)] R1=0.053 2, wR2=0.150 1 R1=0.031 8, wR2=0.094 5 R1=0.037 7, wR2=0.109 2 R indices (all data) R1=0.082 6, wR2=0.136 5 R1=0.034 6, wR2=0.092 0 R1=0.044 9, wR2=0.103 7 Table 2. Selected bond lengths (nm) and angles (°) in complexes 1~3
1 Cu1-N1 0.202 0(5) Cu1-N3 0.190 9(5) Cu1-S1 0.220 2(2) Cu1-Br1 0.232 4(19) S1-Cu1-Br1 96.56(8) N3-Cu1-N1 79.2(2) N3-Cu1-S1 85.38(16) N1-Cu1-S1 163.04(14) N3-Cu1-Br1 177.64(15) N1-Cu1-Br1 99.08(15) 2 Cu1-N1 0.202 5(2) Cu1-N3 0.195 8(2) Cu1-S1 0.224 18(8) Cu1-C11 0.222 86(8) N3-Cu1-N1 79.43(9) N3-Cu1-C11 177.49(6) N3-Cu1-S1 85.74(7) N1-Cu1-C11 98.17(6) N1-Cu1-S1 162.98(6) C11-Cu1-S1 96.74(3) 3 Cu1-O1 0.193 4(2) Cu1-N1 0.200 6(3) Cu1-N3 0.194 0(3) Cu1-S1 0.226 83(9) Cu1-S2 0.283 21(10) Cu2-N6 0.201 1(3) Cu2-N8 0.194 3(3) Cu2-O2 0.194 6(2) Cu2-S1 0.277 58(10) Cu2-S2 0.226 50(9) O1-Cu1-N3 172.39(10) O1-Cu1-N1 92.70(10) O1-Cu1-S1 100.73(7) O1-Cu1-S2 92.80(8) O2-Cu2-N6 96.10(10) O2-Cu2-S1 97.20(8) O2-Cu2-S2 96.39(7) S1-Cu1-S2 95.37(3) S2-Cu2-S1 97.01(3) N1-Cu1-S1 164.24(8) N1-Cu1-S2 92.14(8) N3-Cu1-N1 80.00(10) N3-Cu1-S1 86.20(8) N3-Cu1-S2 89.63(8) N6-Cu2-S2 162.31(8) N6-Cu2-S1 93.80(8) N8-Cu2-N6 79.86(10) N8-Cu2-S2 86.15(8) N8-Cu2-O2 171.97(10) N8-Cu2-S1 90.02(8) Table 3. Hydrogen bond parameters for complexes 1~3
D-H …A d(D-H) / nm d(H …A) / nm d(D …A)/ nm ∠D-H…A/(°) 1 N5-H5 …O1 0.086 0.198 0.279 1(8) 158 2 O2 …Cllⅰ — — 0.331 9 — O2 …O2ⅰ — — 0.281 9 — O1 …O1ⅱ — — 0.282 2 — O1 …N2ⅲ — — 0.229 5 — N5-H5 …O1 0.086 0.210 0.293 2(3) 162.0 3 N5-H5 …O6ⅳ 0.086 0.211 0.293 2(5) 160.4 N10-H10 …O5 0.086 0.207 0.286 4(4) 153.5 O5-H5D …O4ⅴ 0.085 0.198 0.282 3(4) 168.6 O5-H5C …N2ⅵ 0.085 0.225 0.301 6(4) 150.8 O6-H4 …O6 0.082 0.210 0.279 8(4) 142.8 Symmetry codes: ⅰ 1-x, -y, -1-z; ⅱ 1-x, -1-y, -1-z; ⅲ -1+x, -1+y, -1+z; ⅳ x+1, y, z; ⅴ x, -1+y, z; ⅵ -x, 1-y, -z -

计量
- PDF下载量: 9
- 文章访问数: 766
- HTML全文浏览量: 36